Karyopharm Therapeutics Inc. (KPTI) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Total Current Assets | 126.33M | 103.15M | 89.75M | 97.87M | 120.24M | 156.49M | 184.75M | 208.54M | 198.37M | 233.92M | 263.22M | 291.38M | 318.54M | 350.16M | 222.68M | 242.45M | 276.53M | 275.61M | 241.58M | 273.5M |
| Cash & Short-Term Investments | 90.85M | 63.74M | 45.88M | 51.7M | 69.94M | 108.71M | 133.53M | 152.12M | 148.58M | 191.44M | 208.31M | 236.76M | 260.38M | 277.97M | 148.38M | 170.85M | 205.31M | 228.62M | 204.21M | 235.89M |
| Cash Only | 90.85M | 60.54M | 37.67M | 38.73M | 38.78M | 62.48M | 72.83M | 84.77M | 30.63M | 52.23M | 43.66M | 80.89M | 84.06M | 135.19M | 71.35M | 82.25M | 153.26M | 190.46M | 137.4M | 141.31M |
| Short-Term Investments | 0 | 3.2M | 8.21M | 12.97M | 31.16M | 46.24M | 60.7M | 67.35M | 117.95M | 139.21M | 164.66M | 155.87M | 176.32M | 142.78M | 77.03M | 88.6M | 52.05M | 38.16M | 66.81M | 94.58M |
| Accounts Receivable | 23.36M | 26.18M | 31.88M | 32.93M | 35.24M | 30.77M | 31.78M | 37.99M | 31.08M | 26.96M | 37.92M | 32.28M | 35.2M | 47.09M | 27.45M | 23.48M | 24.99M | 22.5M | 18.75M | 17.89M |
| Days Sales Outstanding | 63.57 | 78.36 | 67.69 | 81.78 | 98.96 | 94.2 | 82.76 | 73.46 | 79.73 | 88.44 | 89.68 | 81.7 | 95.69 | 102.1 | 64.81 | 55.58 | 44.83 | 15.03 | 44.72 | 71.93 |
| Inventory | 3.6M | 4.04M | 3.97M | 4.99M | 4.77M | 4.74M | 4.67M | 3.48M | 2.77M | 3.04M | 3.1M | 3.67M | 3.83M | 4.22M | 4.25M | 3.47M | 3.87M | 4.11M | 3.94M | 3.9M |
| Days Inventory Outstanding | 253.25 | 248.1 | 195.02 | 422.57 | 328.87 | 325.25 | 288.31 | 182.61 | 132.49 | 180.94 | 342.2 | 285.77 | 268.17 | 208.65 | 362.32 | 355.86 | 251.82 | 498.99 | 612.92 | 280.64 |
| Other Current Assets | 8.53M | 0 | 8.03M | 8.25M | 10.29M | 12.28M | 14.78M | 14.95M | 15.94M | 12.47M | 13.88M | 18.66M | 19.13M | 20.89M | 32.55M | 33.22M | 30.15M | 6.35M | 2.4M | 762K |
| Total Non-Current Assets | 5.08M | 5.27M | 6.49M | 7.01M | 7.47M | 7.93M | 4.72M | 5.44M | 6.09M | 6.52M | 6.74M | 6.45M | 7.26M | 8.01M | 8.56M | 14.03M | 17.5M | 29.7M | 12.52M | 13.06M |
| Property, Plant & Equipment | 4.5M | 4.65M | 4.8M | 5.33M | 5.8M | 6.28M | 3.08M | 3.8M | 4.45M | 4.88M | 5.48M | 6.06M | 6.63M | 7.38M | 7.93M | 8.5M | 9.06M | 9.56M | 9.87M | 10.42M |
| Fixed Asset Turnover | 7.66x | 7.21x | 8.70x | 6.82x | 4.97x | 6.52x | 11.27x | 10.37x | 7.10x | 6.51x | 6.24x | 5.92x | 5.53x | 4.39x | 4.40x | 4.52x | 5.12x | 13.00x | 3.71x | 2.11x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 317K | 351K | 350K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2M | 2.01M |
| Other Non-Current Assets | 267K | 267K | 1.33M | 1.68M | 1.67M | 1.64M | 1.64M | 1.64M | 1.64M | 1.64M | 1.26M | 387K | 634K | 633K | 626K | 5.53M | 8.44M | 20.14M | 639K | 639K |
| Total Assets | 131.42M | 108.42M | 96.23M | 104.88M | 127.71M | 164.42M | 189.48M | 213.98M | 204.46M | 240.44M | 269.96M | 297.83M | 325.8M | 358.17M | 231.24M | 256.48M | 294.03M | 305.31M | 254.09M | 286.57M |
| Asset Turnover | 0.29x | 0.33x | 0.44x | 0.33x | 0.21x | 0.17x | 0.19x | 0.20x | 0.15x | 0.13x | 0.13x | 0.12x | 0.11x | 0.11x | 0.15x | 0.14x | 0.16x | 0.45x | 0.14x | 0.08x |
| Asset Growth % | 2.9% | -34.06% | -49.21% | -50.99% | -37.54% | -31.62% | -29.81% | -28.15% | -37.24% | -32.87% | 16.75% | 16.12% | 10.8% | 17.32% | -9% | -10.5% | 6.96% | -2.47% | -24.73% | -24.59% |
| Total Current Liabilities | 117.3M | 92.06M | 87.16M | 99.22M | 90.37M | 92.26M | 61.49M | 57.62M | 65.34M | 69.48M | 62.08M | 58.93M | 61.55M | 65.91M | 61.76M | 62.54M | 66.34M | 73.72M | 68.87M | 58.12M |
| Accounts Payable | 4.28M | 4M | 5.39M | 2.6M | 5.87M | 5.11M | 5.78M | 2.8M | 5.03M | 3.12M | 943K | 2.29M | 9.04M | 2.77M | 813K | 1.69M | 3.44M | 1.6M | 881K | 2.31M |
| Days Payables Outstanding | 274.64 | 291.22 | 173.92 | 366.64 | 379.75 | 376.36 | 303.6 | 228.82 | 185.81 | 119.66 | 163.1 | 431.83 | 393.64 | 88.31 | 117.68 | 248.77 | 159.14 | 153.99 | 249.13 | 213.87 |
| Short-Term Debt | 33.25M | 21.01M | 13.67M | 30.73M | 24.46M | 24.43M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 79.77M | 1.58M | 67.17M | 1.57M | 1.94M | 15.56M | 1.94M | 1.47M | 2.04M | 18.16M | 2.23M | 1.75M | 2.5M | 21.47M | 2.46M | 1.86M | 2.06M | 20.36M | 1.12M | 524K |
| Current Ratio | 1.08x | 1.12x | 1.03x | 0.99x | 1.33x | 1.70x | 3.00x | 3.62x | 3.04x | 3.37x | 4.24x | 4.94x | 5.17x | 5.31x | 3.61x | 3.88x | 4.17x | 3.74x | 3.51x | 4.71x |
| Quick Ratio | 1.05x | 1.08x | 0.98x | 0.94x | 1.28x | 1.64x | 2.93x | 3.56x | 2.99x | 3.32x | 4.19x | 4.88x | 5.11x | 5.25x | 3.54x | 3.82x | 4.11x | 3.68x | 3.45x | 4.64x |
| Cash Conversion Cycle | 42.18 | 35.25 | 88.78 | 137.72 | 48.08 | 43.08 | 67.47 | 27.26 | 26.41 | 149.72 | 268.78 | -64.36 | -29.79 | 222.44 | 309.45 | 162.67 | 137.51 | 360.03 | 408.5 | 138.7 |
| Total Non-Current Liabilities | 279.76M | 309.28M | 278.33M | 244.59M | 243.22M | 258.17M | 287.63M | 288.5M | 308.07M | 307.17M | 308.28M | 310.15M | 309.42M | 308.92M | 309.75M | 310.27M | 310.77M | 311.26M | 311.2M | 311.58M |
| Long-Term Debt | 192.16M | 205.88M | 176.74M | 152.25M | 154.83M | 162.95M | 190.59M | 191.13M | 171.13M | 170.92M | 170.7M | 170.5M | 170.31M | 170.1M | 169.89M | 169.69M | 169.49M | 169.29M | 169.09M | 168.9M |
| Capital Lease Obligations | 5.47M | 5.74M | 6.01M | 6.25M | 6.49M | 6.71M | 0 | 955K | 1.88M | 2.79M | 3.67M | 4.5M | 5.31M | 6.1M | 6.86M | 7.58M | 8.29M | 8.97M | 9.63M | 10.2M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 9.8M | 25.32M | 22.08M | 86.09M | 81.91M | 88.51M | 97.04M | 96.41M | 135.06M | 133.46M | 133.91M | 135.15M | 133.8M | 132.72M | 133M | 133M | 133M | 133M | 132.48M | 132.48M |
| Total Liabilities | 397.06M | 401.34M | 365.49M | 343.81M | 333.6M | 350.44M | 349.12M | 346.12M | 373.41M | 376.64M | 370.36M | 369.08M | 370.97M | 374.83M | 371.52M | 372.82M | 377.11M | 384.98M | 380.07M | 369.7M |
| Total Debt | 230.87M | 233.61M | 196.42M | 190.62M | 186.7M | 194.52M | 194.26M | 195.63M | 176.44M | 177.02M | 177.56M | 178.08M | 178.59M | 179.07M | 179.53M | 179.89M | 180.24M | 180.58M | 180.89M | 181.18M |
| Net Debt | 140.02M | 173.07M | 158.75M | 151.89M | 147.92M | 132.05M | 121.43M | 110.86M | 145.81M | 124.78M | 133.91M | 97.19M | 94.53M | 43.89M | 108.18M | 97.64M | 26.98M | -9.88M | 43.49M | 39.87M |
| Debt / Equity | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.83x | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -0.21x | - | - |
| Interest Coverage | -2.13x | -7.10x | -2.06x | -2.31x | -1.13x | -1.76x | -1.81x | 3.67x | -5.34x | -5.72x | -4.68x | -4.62x | -4.92x | -5.53x | -4.93x | -6.75x | -5.17x | 5.86x | -5.46x | -9.69x |
| Total Equity | -265.65M | -292.93M | -269.26M | -238.93M | -205.88M | -186.02M | -159.65M | -132.14M | -168.96M | -136.21M | -100.4M | -71.25M | -45.17M | -16.66M | -140.28M | -116.34M | -83.08M | -79.67M | -125.98M | -83.13M |
| Equity Growth % | -29.03% | -57.47% | -68.66% | -80.81% | -21.86% | -36.57% | -59.02% | -85.46% | -274.01% | -717.76% | 28.43% | 38.76% | 45.63% | 79.09% | -11.35% | -39.94% | -109.58% | -257.62% | -250.38% | -164.05% |
| Book Value per Share | -10.75 | -16.29 | -31.06 | -27.72 | -24.31 | -22.17 | -19.16 | -12.84 | -21.95 | -17.80 | -13.16 | -0.62 | -5.97 | -0.19 | -1.75 | -1.46 | -1.07 | -0.92 | -1.67 | -1.11 |
| Total Shareholders' Equity | -265.65M | -292.93M | -269.26M | -238.93M | -205.88M | -186.02M | -159.65M | -132.14M | -168.96M | -136.21M | -100.4M | -71.25M | -45.17M | -16.66M | -140.28M | -116.34M | -83.08M | -79.67M | -125.98M | -83.13M |
| Common Stock | 14K | 14K | 13K | 13K | 13K | 13K | 13K | 13K | 12K | 12K | 12K | 12K | 12K | 12K | 8K | 8K | 8K | 8K | 8K | 8K |
| Retained Earnings | -1.78B | -1.76B | -1.66B | -1.62B | -1.59B | -1.56B | -1.53B | -1.5B | -1.52B | -1.49B | -1.45B | -1.41B | -1.38B | -1.34B | -1.31B | -1.27B | -1.22B | -1.18B | -1.22B | -1.17B |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 43K | 71K | -259K | -251K | -321K | -356K | -222K | -605K | -518K | -161K | -742K | -783K | -419K | -638K | -752K | -538K | 87K | 191K | 372K | 196K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |